See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.33▲ 1.43%
B3 Stock Exchange · Brazil · Updated after 27 Oct 2026 close

DaVita Inc.

DVAI34 · B3 Stock Exchange · prices in BRL
BRL 966.24▼ -27.36 (2.75%)
Research reportHistorical data

About DaVita Inc.

DaVita Inc. provides kidney care services, chiefly dialysis treatment for people whose kidneys no longer work well enough on their own. The company runs outpatient dialysis centers and also offers related laboratory, pharmacy and vascular access services, along with home dialysis support. Its patients are individuals with chronic kidney disease and end-stage renal failure, and much of its care is delivered in the United States, with some operations abroad. DaVita is based in Denver, Colorado.

DaVita Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code DVAI34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

48/ 100
Market X-Ray · price-based
Weak price profile
Ranks #815 of 1455 on the B3 Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendFair
52/100
Mixed trend against its averages.
See the numbers →
Above 200-day average7.1%
From 52-week high-21.9%
MomentumFair
58/100
Typical recent returns for this exchange.
See the numbers →
3-month return-20.3%
6-month return28.8%
12-month, skipping last month34.4%
Stability (higher is calmer)Weak
42/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)47.9%
Worst drawdown, 1 year (smaller is calmer)-29.0%
LiquidityWeak
33/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M BRL
Zero-volume days23.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
Price trend
Uptrend
Versus its 50- and 200-day averages
52-week range
546.63 – 1,253.26
Price is 59% of the way up
Returns
−20.3% 3m · +40.4% 1y
Price returns, dividends not included
RSI (14)
56
Neutral zone

Price chart

52-wk range 546.63 – 1,253.26 Daily closes, split-adjusted

Signals

50-day average929.19
200-day average902.57
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)29.80

Technical summary

Daily
Bullish
10 bullish · 3 neutral · 3 bearish
Weekly
Strongly bullish
8 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10921.8Bullish
EMA 10931.4Bullish
SMA 20916.5Bullish
EMA 20926.7Bullish
SMA 50929.2Bullish
EMA 50947.3Bullish
SMA 1001,023.2Bearish
EMA 100957.2Bullish
SMA 200902.6Bullish
EMA 200918.4Bullish
Oscillators (daily)
RSI (14)56.27Neutral
MACD (12, 26)-0.05Bearish
Momentum (12)6.96Bullish
Stochastic %K (14)53.10Neutral
Williams %R (14)-46.90Neutral
CCI (20)147.5Bearish
Pivot points (classic, last session)
S3
948.4
S2
954.4
S1
960.3
Pivot
966.2
R1
972.2
R2
978.1
R3
984.1
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in BRL. Educational only, not financial advice.